SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-023369
Filing Date
2013-05-01
Accepted
2013-05-01 16:53:21
Documents
1
Period of Report
2013-04-29

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c530081_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c530081_4x0.xml 4 2906
  Complete submission text file 0001209191-13-023369.txt   4207
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
TIDMARSH GEORGE F (Reporting) CIK: 0001287235 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24274 | Film No.: 13803925